FDA Investigator Gloria E Parra
Gloria E Parra has conducted inspections on 8 sites in 3 countries as of 20 Oct 2003. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
20 Oct 2003
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Switzerland,
United States of America,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Gloria E Parra:
Alia Legaux,
Amy Wyan Mai,
Anita Narula, PhD,
Ariel Cruz Figueroa,
Arsen Karapetyan,
Barbara M Frazier,
Burnell M Henry,
Chikako Torigoe, PhD,
Christian D Lynch (CDL),
Craig A Garmendia,
Donald J Ullstrom,
Dr. Gang Wang, PhD,
Edwin Melendez,
Esteban Beltran,
Evelyn Taha,
Gary T Greco,
Gene D Arcy,
George Pyramides,
Hasan A Irier, PhD,
Haydee B Romero,
Holly Brevig,
Irina Gaberman,
Jacqueline Mdiaz Albertini,
Jagdish R Amin,
James A Liubicich,
James L Dunnie, Jr,
Jason K Morgan,
Jessica M Monteiro,
Jose A Lopez,
Jose Acruz Gonzalez,
Junho Pak,
Larry K Austin,
Laura M Howard,
Laura Schankweiler,
Leena Thomas,
Li Hongpaul Yeh, PhD,
Lisa Mathew,
LTJG Matthew R Palo,
Matthew A Spataro,
Melissa D Ray,
Mercy O Quagraine,
Michael A Charles,
Michael E Maselli,
Michael R Dominick,
Michael R Goga,
Michelle Yclark Stuart,
Mohammad Heidaran, PhD,
Mohsen Rajabi Abhari, FDA,
Mra Mcculloughj,
Niketa Patel,
Parul M Patel,
Patricia F Hughes, PhD,
Patrick L Wisor,
Peter Abel,
Prabhu P Raju,
Rebecca E Dombrowski,
Reyes Candau Chacon, PhD,
Samina S Khan,
Sandra D Thompson,
Shirley J Berryman,
Sidney B Priesmeyer,
Simone E Pitts,
Steven M Weinman,
Tawny L Colling,
Thomas J Arista,
Thomas W Nojek,
Thuy T Nguyen, LCDR,
Tina M Pawlowski,
Torrance J Slayton,
Uduak M Inokon,
Valerie Jgrecek Trinh,
Wayne E Seifert,
Xianghong Jing (Emily), PhD,
Yumi J Hiramine
Gloria E Parra's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| May, 2001 | EIR | New York Blood Center, Inc. - EIR, 2001-05-21 |
| September, 2002 | EIR | Pfizer, Inc. - EIR, 2002-09-27 |
| November, 2003 | FDA 483 | Norton Healthcare Limited - Form 483, 2003-11-04 |
| May, 2001 | FDA 483 Response | New York Blood Center, Inc. - Form 483R, 2001-08-15 |
| May, 2001 | FDA 483 | New York Blood Center, Inc. - Form 483, 2001-05-21 |
| November, 2002 | EIR | Senn Chemicals AG - EIR, 2002-11-21 |
| November, 2002 | FDA 483 Response | Senn Chemicals AG - Form 483R, 2002-12-20 |
| November, 2002 | FDA 483 | Senn Chemicals AG - Form 483, 2002-11-21 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more